On 21 April 2026, EC Healthcare announced that the seller of its minority interest in the unnamed Target Company has exercised a previously granted put option, requiring EC Healthcare’s indirect wholly owned subsidiary (the Purchaser) to acquire the seller’s remaining 10% stake.

The put-option exercise price is HK$6.00 million, calculated with reference to the FY25 Cash EBITDA agreed by both parties. EC Healthcare will fund the payment entirely through internal resources.

Following completion, the Target Company will become a wholly owned subsidiary of EC Healthcare. The group confirms that the transaction will not affect the Target Company’s existing business or operations, and the entity will continue to be consolidated into EC Healthcare’s financial statements.

The put-option exercise complies with Rule 14.74(2) of the Hong Kong Listing Rules. The board of EC Healthcare, chaired by Executive Director Mr. Tang Chi Fai, approved the related announcement released on 21 April 2026.